Afuco™ Anti-Human LY75 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-LY75 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The monoclonal antibodies which bind to human DEC-205 can be used in a variety of dendritic cell-targeted therapies, for example, to enhance antigen presentation and/or induce T cell responses, such as cytotoxic T cell (CTL) responses, against a variety of target cells or pathogens, or to treat antigen presenting cell (APC)-mediated diseases.
Supplier Creative Biolabs
Product # AFC-487CL
Pricing Inquiry
Host Human
Target LY75
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.
Feedback